Jeffrey Blizard - Jun 2, 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
President
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Jun 2, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 04:59 PM
Previous filing
May 30, 2025
Next filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blizard Jeffrey President C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN /s/ Megan Smeykal, Attorney-in-fact 2025-06-02 0002012926

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +105K +731.59% $0.00 119K Jun 2, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +154K $0.00 154K Jun 2, 2025 Common Stock 154K $1.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in four equal annual installments beginning on June 2, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 The option vests 25% on June 2, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.